Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice-Reference-Cited by-同舟云学术

Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice

Published:2020-10-01 Issue:8 Volume:35 Page:558-562
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Wojdowska Wioletta¹,Karczmarczyk Urszula¹,Balog Lajos²,Sawicka Agnieszka¹,Pöstényi Zita³,Kovács-Haász Veronika⁴,Polyák András⁵,Laszuk Ewa¹,Mikołajczak Renata¹,Garnuszek Piotr¹

Affiliation:

1. National Centre for Nuclear Research, Radioisotope Centre POLATOM, Research and Development Department, Otwock, Poland.

2. Gamma-VET Ltd, Budapest, Hungary.

3. Synlab Budapest Diagnostic Center, Microbiology Laboratory Synlab Hungary Ltd, Budapest, Hungary.

4. National Public Health Center, National Research Directorate on Radiobiology and Radiohygiene, Budapest, Hungary.

5. Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2019.3405

Reference21 articles.

1. 99mTc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients

2. Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with 90Y and 111In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity standardization and half-life measurement of 177Lu;Applied Radiation and Isotopes;2023-07

2. In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model;Diagnostics;2023-01-08

3. Does the Number of Bifunctional Chelators Conjugated to a mAb Affect the Biological Activity of Its Radio-Labeled Counterpart? Discussion Using the Example of mAb against CD-20 Labeled with ⁹⁰Y or ¹⁷⁷Lu;Journal of Medicinal Chemistry;2022-04-20

4. Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma;British Journal of Cancer;2021-10-20

5. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model;Pharmaceutics;2021-01-13